Strata Critical Medical, Inc.
SRTA· Nasdaq
SRTAStrata Critical Medical, Inc.
Source filing unavailable
| Metric | Q4 2021 | Q4 2020 |
|---|---|---|
| Revenue | $24.62M | $7.99M |
| Net Income | $772.00K | -$2.36M |
| EPS Diluted | $0.01 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
